Bonesupport Holding AB (OTCPK:BOEUF)
$ 21.4 (0%) Market Cap: 1.38 Bil Enterprise Value: 1.33 Bil PE Ratio: 72.85 PB Ratio: 14.16 GF Score: 81/100

Q1 2026 Bonesupport Holding AB Earnings Call Transcript

Apr 22, 2026 / 08:00AM GMT
Release Date Price: $28.5

Key Points

Positve
  • Bonesupport Holding AB (BOEUF) reported a strong Q1 2026 with net sales of SEK324 million, reflecting a 31% growth at constant exchange rates compared to Q1 2025.
  • The company achieved a solid adjusted operating result of SEK85 million, corresponding to an adjusted operating margin of 26%.
  • Sales of CERMAT-G in the US reached SEK222 million, showing significant growth from SEK178 million in Q1 2025.
  • The company successfully launched its first CERMET sales in India, marking an expansion into new markets.
  • Bonesupport Holding AB (BOEUF) maintained a strong cash position of SEK455 million at the end of the quarter, underscoring its financial stability.
Negative
  • The reported growth was only 14%, indicating a strong negative currency impact on the financial results.
  • Selling and marketing expenses increased, impacting the operating margin, with costs rising to SEK128.4 million from SEK121.6 million the previous year.
  • The regulatory process for CERMET V in the US is ongoing, with potential delays due to the FDA's de novo process requirements.
  • The company faces geopolitical uncertainties in the Middle East, affecting market presence and logistics.
  • US BVF sales were flat year-over-year at constant exchange rates, indicating challenges in this product segment.
Torbjoern Skoeld
Bonesupport Holding AB - Chief Executive Officer

Thank you, operator. Welcome, everyone to BoneSupport's Q1 2026 results call. My name is Torbjeom Skoeld, CEO of BoneSupport. With me here today is our CFO, Hakan Johansson, and together, we will use the next 25 minutes to guide you through the Q1 presentation and then open the line for questions.

Before starting the presentation, I would like to draw your attention to the disclaimers covering any forward-looking statements we will make today.

So let's look at the financial and operational highlights of the quarter. Q1 was another strong quarter with solid execution across the business. Net sales came in at SEK324 million, corresponding to a growth at constant exchange rates of 31% versus Q1 2025. Reported growth was 14%, showing that there was a continued strong currency impact on our figures for the quarter.

Our adjusted operating result, excluding incentive program effects, was SEK85 million, corresponding to an adjusted operating margin of 26%.

Reported operating result was SEK72 million.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot